# Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)

> **NCT03008044** · NA · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 12 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DEVICE:** FiberSense system

## Key facts

- **NCT ID:** NCT03008044
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03008044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03008044, "Evaluation of a Percutaneous Optical Fibre Glucose Sensor (FiberSense System)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03008044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*